Financials Al-Razi Medical Company
Equities
9572
SA15R0E4LI18
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52 SAR | +7.22% |
|
+8.00% | -13.04% |
Valuation
Fiscal Period: December | 2023 |
---|---|
Capitalization 1 | 90.9 |
Enterprise Value (EV) 1 | 100.7 |
P/E ratio | 133 x |
Yield | - |
Capitalization / Revenue | 1.48 x |
EV / Revenue | 1.64 x |
EV / EBITDA | 36 x |
EV / FCF | -371,731,698 x |
FCF Yield | -0% |
Price to Book | 4.06 x |
Nbr of stocks (in thousands) | 1,520 |
Reference price 2 | 59.80 |
Announcement Date | 04/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net sales 1 | 45.19 | 52.39 | 61.33 |
EBITDA 1 | 3.316 | 3.636 | 2.8 |
EBIT 1 | 2.42 | 2.574 | 1.372 |
Operating Margin | 5.36% | 4.91% | 2.24% |
Earnings before Tax (EBT) 1 | 2.533 | 2.425 | 1.086 |
Net income 1 | 2.163 | 2.014 | 0.686 |
Net margin | 4.79% | 3.84% | 1.12% |
EPS 2 | 1.423 | 1.325 | 0.4513 |
Free Cash Flow | - | -1.885 | -0.271 |
FCF margin | - | -3.6% | -0.44% |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 26/02/23 | 26/02/23 | 04/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net Debt 1 | - | 6.09 | 9.84 |
Net Cash position 1 | 1.21 | - | - |
Leverage (Debt/EBITDA) | - | 1.676 x | 3.515 x |
Free Cash Flow | - | -1.88 | -0.27 |
ROE (net income / shareholders' equity) | - | 8.43% | 2.98% |
ROA (Net income/ Total Assets) | - | 3.88% | 1.94% |
Assets 1 | - | 51.88 | 35.31 |
Book Value Per Share 2 | 15.90 | 15.50 | 14.70 |
Cash Flow per Share 2 | 5.120 | 1.000 | 0.5600 |
Capex 1 | 1.11 | 2.69 | 4.78 |
Capex / Sales | 2.46% | 5.14% | 7.79% |
Announcement Date | 26/02/23 | 26/02/23 | 04/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-13.04% | 19.65M | |
-14.20% | 8.3B | |
-4.01% | 1.36B | |
+4.91% | 1.31B | |
-34.67% | 1B | |
-30.84% | 697M | |
-.--% | 619M | |
+6.60% | 473M | |
+1.81% | 432M | |
-36.52% | 270M |
- Stock Market
- Equities
- 9572 Stock
- Financials Al-Razi Medical Company